115 related articles for article (PubMed ID: 27804311)
1. Systemic matrix metalloproteinase-8 response in chronic tonsillitis.
Ilmarinen T; Lont T; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Munck-Wickland E; Ramqvist T; Dalianis T; Aaltonen LM
Infect Dis (Lond); 2017 Apr; 49(4):302-307. PubMed ID: 27804311
[TBL] [Abstract][Full Text] [Related]
2. The role of matrix metalloproteinases in recurrent tonsillitis.
Acioglu E; Yigit O; Alkan Z; Server EA; Uzun H; Gelisgen R
Int J Pediatr Otorhinolaryngol; 2010 May; 74(5):535-9. PubMed ID: 20233630
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma.
Lempinen M; Lyytinen I; Nordin A; Tervahartiala T; Mäkisalo H; Sorsa T; Isoniemi H
Ann Med; 2013 Nov; 45(7):482-7. PubMed ID: 23962148
[TBL] [Abstract][Full Text] [Related]
4. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Pakkanen PP; Aaltonen LM; Sorsa TA; Tervahartiala TI; Hagström JK; Ilmarinen TT
Head Neck; 2019 Feb; 41(2):309-314. PubMed ID: 30549356
[TBL] [Abstract][Full Text] [Related]
5. Association of thalassemia major and gingival inflammation: A pilot study.
Gümüş P; Kahraman-Çeneli S; Akcali A; Sorsa T; Tervahartiala T; Buduneli N; Özçaka Ö
Arch Oral Biol; 2016 Apr; 64():80-4. PubMed ID: 26799499
[TBL] [Abstract][Full Text] [Related]
6. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
7. Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease.
Yıldırım E; Kormi I; Başoğlu ÖK; Gürgün A; Kaval B; Sorsa T; Buduneli N
J Periodontal Res; 2013 Jun; 48(3):269-75. PubMed ID: 22967248
[TBL] [Abstract][Full Text] [Related]
8. Plasma level of tissue inhibitor of matrix metalloproteinase-1 but not that of matrix metalloproteinase-8 predicts survival in head and neck squamous cell cancer.
Pradhan-Palikhe P; Vesterinen T; Tarkkanen J; Leivo I; Sorsa T; Salo T; Mattila PS
Oral Oncol; 2010 Jul; 46(7):514-8. PubMed ID: 20371206
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
[TBL] [Abstract][Full Text] [Related]
10. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Marcaccini AM; Novaes AB; Meschiari CA; Souza SL; Palioto DB; Sorgi CA; Faccioli LH; Tanus-Santos JE; Gerlach RF
Clin Chim Acta; 2009 Nov; 409(1-2):117-22. PubMed ID: 19751716
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-risk human papillomavirus infection and cancer gene mutations in nonmalignant tonsils.
Ilmarinen T; Munne P; Hagström J; Haglund C; Auvinen E; Virtanen EI; Haesevoets A; Speel EJM; Aaltonen LM
Oral Oncol; 2017 Oct; 73():77-82. PubMed ID: 28939080
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis of Human Papillomavirus Type 16 in Tonsillar Squamous Cell Carcinoma.
Hassani S; Castillo A; Ohori J; Higashi M; Kurono Y; Akiba S; Koriyama C
Anticancer Res; 2015 Dec; 35(12):6633-8. PubMed ID: 26637879
[TBL] [Abstract][Full Text] [Related]
13. Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level.
Buduneli E; Mäntylä P; Emingil G; Tervahartiala T; Pussinen P; Barış N; Akıllı A; Atilla G; Sorsa T
J Periodontol; 2011 May; 82(5):716-25. PubMed ID: 21091346
[TBL] [Abstract][Full Text] [Related]
14. Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Sivula M; Hästbacka J; Kuitunen A; Lassila R; Tervahartiala T; Sorsa T; Pettilä V
Acta Anaesthesiol Scand; 2015 Feb; 59(2):176-84. PubMed ID: 25329743
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
16. Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study.
Nukarinen E; Lindström O; Kuuliala K; Kylänpää L; Pettilä V; Puolakkainen P; Kuuliala A; Hämäläinen M; Moilanen E; Repo H; Hästbacka J
PLoS One; 2016; 11(8):e0161480. PubMed ID: 27561093
[TBL] [Abstract][Full Text] [Related]
17. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation.
Kim SH; Koo BS; Kang S; Park K; Kim H; Lee KR; Lee MJ; Kim JM; Choi EC; Cho NH
Int J Cancer; 2007 Apr; 120(7):1418-25. PubMed ID: 17205528
[TBL] [Abstract][Full Text] [Related]
18. Gingival crevicular fluid and serum matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 levels in renal transplant patients undergoing different immunosuppressive therapy.
Emingil G; Afacan B; Tervahartiala T; Töz H; Atilla G; Sorsa T
J Clin Periodontol; 2008 Mar; 35(3):221-9. PubMed ID: 18269661
[TBL] [Abstract][Full Text] [Related]
19. Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
Mäkitalo L; Rintamäki H; Tervahartiala T; Sorsa T; Kolho KL
Scand J Gastroenterol; 2012 Jul; 47(7):785-94. PubMed ID: 22519363
[TBL] [Abstract][Full Text] [Related]
20. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
